메뉴 건너뛰기




Volumn 58, Issue 1, 2010, Pages 20-23

Lycopene in treatment of high-grade gliomas: A pilot study

Author keywords

Chemotherapy; High grade glioma; Lycopene; Radiotherapy

Indexed keywords

LYCOPENE; PACLITAXEL; PLACEBO;

EID: 77949650906     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.60389     Document Type: Article
Times cited : (19)

References (22)
  • 1
    • 32844462426 scopus 로고    scopus 로고
    • Brain tumor and role of beta-carotene, a-tocopherol, superoxide dismutase and glutathione peroxidase
    • Aggarwal S, Subberwal M, Kumar S, Sharma M. Brain tumor and role of beta-carotene, a-tocopherol, superoxide dismutase and glutathione peroxidase. J Cancer Res Ther 2006;2:24-27
    • (2006) J Cancer Res Ther , vol.2 , pp. 24-27
    • Aggarwal, S.1    Subberwal, M.2    Kumar, S.3    Sharma, M.4
  • 2
    • 33845301978 scopus 로고    scopus 로고
    • Chemopreventive agents alters global gene expression pattern: Predicting their mode of action and targets
    • Narayanan BA. Chemopreventive agents alters global gene expression pattern: Predicting their mode of action and targets. Curr Cancer Drug Targets 2006;6:711-727
    • (2006) Curr Cancer Drug Targets , vol.6 , pp. 711-727
    • Narayanan, B.A.1
  • 4
    • 0025314685 scopus 로고
    • Role of oxygen free radicals in carcinogenesis and brain ischemia
    • Floyd RA. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 1990;4:2587-2597
    • (1990) FASEB J , vol.4 , pp. 2587-2597
    • Floyd, R.A.1
  • 6
    • 0032543363 scopus 로고    scopus 로고
    • Cancer prevention by carotenoids
    • Nishino H. Cancer prevention by carotenoids. Mutat Res 1998;402:159-163
    • (1998) Mutat Res , vol.402 , pp. 159-163
    • Nishino, H.1
  • 7
    • 0041829262 scopus 로고    scopus 로고
    • The potential for strategies using micronutrients and heterocyclic drugs to treat invasive gliomas
    • Rooprai HK, Christidou M, Pilkington GJ. The potential for strategies using micronutrients and heterocyclic drugs to treat invasive gliomas. Acta Neurochir (Wien) 2003;145:683-690
    • (2003) Acta Neurochir (Wien) , vol.145 , pp. 683-690
    • Rooprai, H.K.1    Christidou, M.2    Pilkington, G.J.3
  • 9
    • 0041910043 scopus 로고    scopus 로고
    • A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer
    • Ansari MS, Gupta NP. A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. BJU Int 2003;92:375-378
    • (2003) BJU Int , vol.92 , pp. 375-378
    • Ansari, M.S.1    Gupta, N.P.2
  • 10
    • 0024690170 scopus 로고
    • Inhibitory effects of carotenoids and retinoids on the in vitro growth of rat C-6 glioma cells
    • Wang CJ, Lin JK. Inhibitory effects of carotenoids and retinoids on the in vitro growth of rat C-6 glioma cells. Proc Natl Sci Counc Repub China B 1989;13:176-183
    • (1989) Proc Natl Sci Counc Repub China B , vol.13 , pp. 176-183
    • Wang, C.J.1    Lin, J.K.2
  • 11
    • 0024424246 scopus 로고
    • Inhibition of growth and development of the transplantable C-6 glioma cells inoculated in rats by retinoids and carotenoids
    • Wang CJ, Chou MY, Lin JK. Inhibition of growth and development of the transplantable C-6 glioma cells inoculated in rats by retinoids and carotenoids. Cancer Lett 1989;48:135-142
    • (1989) Cancer Lett , vol.48 , pp. 135-142
    • Wang, C.J.1    Chou, M.Y.2    Lin, J.K.3
  • 12
    • 0032496374 scopus 로고    scopus 로고
    • Carotenoid mixtures protect multilamellar liposomes against oxidative damage: Synergistic effects of lycopene and lutein
    • Stahl W, Junghans A, de Boer B, Driomina ES, Briviba K, Sies H. Carotenoid mixtures protect multilamellar liposomes against oxidative damage: Synergistic effects of lycopene and lutein. FEBS Lett 1998;427:305-308
    • (1998) FEBS Lett , vol.427 , pp. 305-308
    • Stahl, W.1    Junghans, A.2    De Boer, B.3    Driomina, E.S.4    Briviba, K.5    Sies, H.6
  • 15
    • 0030474043 scopus 로고    scopus 로고
    • Lycopene: A biologically important carotenoid for humans?
    • Stahl W, Sies H. Lycopene: A biologically important carotenoid for humans? Arch Biochem Biophys 1996;336:1-9.
    • (1996) Arch Biochem Biophys , vol.336 , pp. 1-9
    • Stahl, W.1    Sies, H.2
  • 16
    • 0036785482 scopus 로고    scopus 로고
    • Effect of low dose lycopene intake on lycopene bioavailability and oxidative stress
    • Rao AV, Shen H. Effect of low dose lycopene intake on lycopene bioavailability and oxidative stress. Nutr Res 2002;22:1125-1131
    • (2002) Nutr Res , vol.22 , pp. 1125-1131
    • Rao, A.V.1    Shen, H.2
  • 18
    • 33847660451 scopus 로고    scopus 로고
    • Tomatoes versus lycopene in oxidative stress and carcinogenesis: Conclusions from clinical trials
    • Basu A, Imrhan V. Tomatoes versus lycopene in oxidative stress and carcinogenesis: Conclusions from clinical trials. Eur J Clin Nutr 2007;61:295-303.
    • (2007) Eur J Clin Nutr , vol.61 , pp. 295-303
    • Basu, A.1    Imrhan, V.2
  • 19
    • 0033513280 scopus 로고    scopus 로고
    • Radiation and concomitant weekly administration of paclitaxel in patients with glioblastoma multiforme. A phase II study
    • Fountzilas G, Karavelis A, Capizzello A, Kalogera-Fountzila A, Karkavelas G, Zamboglou N, et al. Radiation and concomitant weekly administration of paclitaxel in patients with glioblastoma multiforme. A phase II study. J Neurooncol 1999;45:159-165
    • (1999) J Neurooncol , vol.45 , pp. 159-165
    • Fountzilas, G.1    Karavelis, A.2    Capizzello, A.3    Kalogera-Fountzila, A.4    Karkavelas, G.5    Zamboglou, N.6
  • 22
    • 65349121788 scopus 로고    scopus 로고
    • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
    • Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459-466
    • (2009) Lancet Oncol , vol.10 , pp. 459-466
    • Stupp, R.1    Hegi, M.E.2    Mason, W.P.3    Van Den Bent, M.J.4    Taphoorn, M.J.5    Janzer, R.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.